PTGX FY 2021 Earnings — Protagonist Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTGXProtagonist Therapeutics, Inc.

$6B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M-4.4% YoY

Gross Profit

$27M100.0% margin

Operating Income

-$126M-460.0% margin

Net Income

-$126M-458.9% margin

EPS (Diluted)

$-2.65

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$109M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$348M

Total Liabilities

$48M

Stockholders' Equity

$300M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$29M	-4.4%
Gross Profit	$27M	$29M	-4.4%
Operating Income	-$126M	-$65M	-95.1%
Net Income	-$126M	-$66M	-89.8%